Expression of the Met-receptor and Its Ligand, HGF-SF During Mouse Embryogenesis
Overview
Authors
Affiliations
We have determined the expression patterns of the met proto-oncogene and the gene which encodes its ligand, scatter factor/hepatocyte growth factor (HGF-SF), during mouse embryogenesis. A recurring pattern of expression was found in a variety of different organs: expression of met in specific epithelial cells, and transcripts for the HGF-SF gene in mesenchymal cells in close vicinity. Exchange of signals between mesenchymal and epithelial cell compartments are important in morphogenesis and differentiation of a variety of embryonal organs, although their molecular basis has not been elucidated. The observed expression of met and HGF-SF during development suggests that this receptor and its specific ligand might play a role in such processes. In addition to this distinct pattern, expression of met in certain epithelia and HGF-SF in the surrounding mesenchyme, we find met transcripts in neural, endothelial and muscle cells and transcripts for HGF-SF in neural and muscle tissue. In no instance did we observe both, transcripts for the receptor and the ligand, in the same cells. This suggests a paracrine mode of action for HGF-SF and its receptor during development. This exchange of signals might thus regulate a variety of processes, notably among them mesenchymal epithelial interactions.
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Perreau M, Suffiotti M, Marques-Vidal P, Wiedemann A, Levy Y, Laouenan C Nat Commun. 2021; 12(1):4888.
PMID: 34373466 PMC: 8352963. DOI: 10.1038/s41467-021-25191-5.
Morell R, Olszewski R, Tona R, Leitess S, Wafa T, Taukulis I J Neurosci. 2020; 40(15):2976-2992.
PMID: 32152201 PMC: 7141880. DOI: 10.1523/JNEUROSCI.2278-19.2020.
Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome.
Cho H, Shan Y, Whittington N, Wray S Front Cell Dev Biol. 2019; 7:121.
PMID: 31355196 PMC: 6637222. DOI: 10.3389/fcell.2019.00121.
Valproic acid, targets papillary thyroid cancer through inhibition of c-Met signalling pathway.
Fu Y, Zheng H, Zhou L, Zhang D, Liu X, Sun H Am J Transl Res. 2017; 9(6):3138-3147.
PMID: 28670399 PMC: 5489911.
Yan Y, Zhu Y, Sun F, Zhang B, Li L, Sun Z Exp Biol Med (Maywood). 2015; 240(4):534-45.
PMID: 25576343 PMC: 4935372. DOI: 10.1177/1535370214548996.